Cargando…
A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203960/ https://www.ncbi.nlm.nih.gov/pubmed/37228598 http://dx.doi.org/10.3389/fimmu.2023.1192395 |
_version_ | 1785045743389638656 |
---|---|
author | Lorenz, Peter Steinbeck, Felix Mai, Franz Reisinger, Emil C. Müller-Hilke, Brigitte |
author_facet | Lorenz, Peter Steinbeck, Felix Mai, Franz Reisinger, Emil C. Müller-Hilke, Brigitte |
author_sort | Lorenz, Peter |
collection | PubMed |
description | BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint immune dominant epitopes that remain immutable in viral variants. METHODS: We used profiling with peptides derived from the Spike surface glycoprotein of SARS-CoV-2 to compare the antibody reactivity landscapes between patients and different vaccine cohorts. Initial screening was done with peptide microarrays while detailed results and validation data were obtained using peptide ELISA. RESULTS: Overall, antibody patterns turned out to be individually distinct. However, plasma samples of patients conspicuously recognized epitopes covering the fusion peptide region and the connector domain of Spike S2. Both regions are evolutionarily conserved and are targets of antibodies that were shown to inhibit viral infection. Among vaccinees, we discovered an invariant Spike region (amino acids 657-671) N-terminal to the furin cleavage site that elicited a significantly stronger antibody response in AZD1222- and BNT162b2- compared to NVX-CoV2373-vaccinees. CONCLUSIONS: Understanding the exact function of antibodies recognizing amino acid region 657-671 of SARS-CoV-2 Spike glycoprotein and why nucleic acid-based vaccines elicit different responses from protein-based ones will be helpful for future vaccine design. |
format | Online Article Text |
id | pubmed-10203960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102039602023-05-24 A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts Lorenz, Peter Steinbeck, Felix Mai, Franz Reisinger, Emil C. Müller-Hilke, Brigitte Front Immunol Immunology BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint immune dominant epitopes that remain immutable in viral variants. METHODS: We used profiling with peptides derived from the Spike surface glycoprotein of SARS-CoV-2 to compare the antibody reactivity landscapes between patients and different vaccine cohorts. Initial screening was done with peptide microarrays while detailed results and validation data were obtained using peptide ELISA. RESULTS: Overall, antibody patterns turned out to be individually distinct. However, plasma samples of patients conspicuously recognized epitopes covering the fusion peptide region and the connector domain of Spike S2. Both regions are evolutionarily conserved and are targets of antibodies that were shown to inhibit viral infection. Among vaccinees, we discovered an invariant Spike region (amino acids 657-671) N-terminal to the furin cleavage site that elicited a significantly stronger antibody response in AZD1222- and BNT162b2- compared to NVX-CoV2373-vaccinees. CONCLUSIONS: Understanding the exact function of antibodies recognizing amino acid region 657-671 of SARS-CoV-2 Spike glycoprotein and why nucleic acid-based vaccines elicit different responses from protein-based ones will be helpful for future vaccine design. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10203960/ /pubmed/37228598 http://dx.doi.org/10.3389/fimmu.2023.1192395 Text en Copyright © 2023 Lorenz, Steinbeck, Mai, Reisinger and Müller-Hilke https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lorenz, Peter Steinbeck, Felix Mai, Franz Reisinger, Emil C. Müller-Hilke, Brigitte A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title | A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title_full | A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title_fullStr | A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title_full_unstemmed | A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title_short | A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
title_sort | linear b-cell epitope close to the furin cleavage site within the s1 domain of sars-cov-2 spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203960/ https://www.ncbi.nlm.nih.gov/pubmed/37228598 http://dx.doi.org/10.3389/fimmu.2023.1192395 |
work_keys_str_mv | AT lorenzpeter alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT steinbeckfelix alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT maifranz alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT reisingeremilc alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT mullerhilkebrigitte alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT lorenzpeter linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT steinbeckfelix linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT maifranz linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT reisingeremilc linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts AT mullerhilkebrigitte linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts |